About: Deferiprone     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FDeferiprone

Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union and in Asia for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program.

AttributesValues
rdf:type
rdfs:label
  • ديفيريبرون
  • Deferiprone
  • Défériprone
  • Deferiprone
  • Deferypron
  • Deferiprona
rdfs:comment
  • ديفيريبرون هو دواء يتمخلب بالحديد ويستعمل في علاج التحميل المفرط للحديد في الثلاسيمية الكبرى. رخص استعماله أول مرة في علاج الثلاسيمية الكبرى في عام 1994 وقد حصل على الترخيص أولا في أوروبا وآسيا لكنه انتظر سنوات عديدة قبل ترخيصه في كندا والولايات المتحدة. ففي 14 أكتوبر 2011, حصل على موافقة في الولايات المتحدة تحت لإدارة الغذاء والدواء.
  • Le défériprone est une molécule chélatrice du fer, utilisé comme médicament dans les surcharges en fer.
  • Il deferiprone è un principio attivo che agisce come ferrochelante; esso è indicato secondo l'RCP nel trattamento dell'accumulo di ferro (emosiderosi) nei pazienti affetti da talassemia maggiore, quando la terapia con deferoxamina è controindicata o non adeguata. Il farmaco è stato studiato dalla ApoPharma. In Italia è commercializzato dalla Chiesi Farmaceutici dal 1999, con il nome: Ferriprox.
  • Deferypron (łac. Deferipronum) – związek chelatujący żelazo, stosowany w leczeniu talasemii.
  • Deferiprona é fármaco usado como agente quelante do ferro. É usado no tratamento de talassemia. A deferiprona é um tratamento alternativo para a sobrecarga de ferro em pacientes com talassemia major incapazes de receber a .
  • Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major. It was first approved and indicated for use in treating thalassaemia major in 1994 and had been licensed for use in the European Union and in Asia for many years while awaiting approval in Canada and in the United States. On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program.
foaf:depiction
  • External Image
foaf:isPrimaryTopicOf
thumbnail
dct:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
ATC prefix
  • V03
c
CAS number
ChEBI
ChEMBL
ChemSpiderID
DrugBank
  • DB08826
elimination half-life
  • 10800.0
excretion
H
IUPAC name
Faceted Search & Find service v1.17_git51 as of Sep 16 2020


Alternative Linked Data Documents: PivotViewer | iSPARQL | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3319 as of Dec 29 2020, on Linux (x86_64-centos_6-linux-glibc2.12), Single-Server Edition (61 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2021 OpenLink Software